SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Trading Statement

1 Nov 2022 07:00

RNS Number : 8199E
TP ICAP Group PLC
01 November 2022
 

TP ICAP GROUP PLC ("TP ICAP" or the "Group")

LEI: 2138006YAA7IRVKKGE63

 

1 November 2022

 

Trading update for the nine months ended 30 September 2022

 

 

Year-to-date performance (in constant currency, unless in brackets, which denotes reported currency)

 

Revenue

 

Total Group revenue of £1,588m in the first nine months of 2022 was up 10% (+15% in reported currency), compared with the same period in 2021. The Group benefitted from favourable market conditions in Global Broking, particularly in Rates, our largest, and most profitable, asset class. The ongoing strengthening of the US Dollar has been a meaningful tailwind: approximately 60% of the Group's revenue (and approximately 40% of costs) are US Dollar denominated. Excluding Liquidnet (completed on 23 March 2021), revenue increased by 7% (+12%).

 

At the divisional level, Global Broking revenue was up 9% (+14%). All asset classes generated high single digit to double digit growth. This performance underlines the strength of the franchise, which is well positioned as Central Banks continue to withdraw liquidity and increase interest rates.

 

In Energy & Commodities (E&C), revenue declined by 3% (+3%), in line with exchange volumes. Oil, our largest asset class in E&C, delivered low single digit growth. As previously reported, the European Gas & Power market is challenging: significant price rises and increased exchange margin requirements resulted in liquidity contracting and low levels of market activity.

 

Agency Execution revenue, including Liquidnet, was up 34% (+40%). Liquidnet revenue, on a proforma basis, declined by 9% (-7%). In Europe, there was a decline in larger block market trading activity. In the US, there was a shift in mix towards lower rate client segments. Liquidnet's market share in the US and Europe was broadly unchanged. Parameta Solutions revenue grew by 6% (+15%), with Data & Analytics (D&A) up 9% (+18%).

 

The Group, as a whole, continues to trade in line with the Board's expectations.

 

Third quarter performance (in constant currency, unless in brackets, which denotes reported currency)

 

During the third quarter of 2022, total Group revenue was £508m, up 5% (+14%) compared with the same period in 2021.

 

Global Broking revenue was up 12% (+20%). All asset classes generated high single digit to double digit growth, reflecting the continued strong performance. E&C revenue declined by 12% (-3%). In Agency Execution, including Liquidnet, revenue declined by 1% (+6%). Liquidnet revenue declined by 22% (-18%), reflecting the market conditions noted above. In addition, US Agency Alternative Trading System (ATS) volumes, a key contributor for Liquidnet, were subdued, compared with exchanges and OTC venues. Parameta Solutions revenue grew by 6% (+22%), while D&A revenue was up 7% (+24%).

 

2022 preliminary results

 

The Group will report its 2022 preliminary results on 14 March 2023. At the results, the Agency Execution division will be reported on a consolidated basis as Liquidnet.

 

Forward looking statements

This document contains forward looking statements with respect to the financial condition, results and business of the Company. By their nature, forward looking statements involve risk and uncertainty and there may be subsequent variations to estimates. The Company's actual future results may differ materially from the results expressed or implied in these forward-looking statements.

 

Enquiries:

Analysts and investors Dominic Lagan Direct: +44 (0) 20 3933 0447

Email: dominic.lagan@tpicap.com  

Media Richard Newman Direct: +44 (0) 7469 039 307

Email: richard.newman@tpicap.com

  

About TP ICAP

· TP ICAP connects buyers and sellers in global financial, energy and commodities markets.

· It is the world's leading wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world.

· We operate from more than 60 offices across 27 countries, supporting brokers with award-winning and market-leading technology.

 

Further information on the company and its activities is available on the Company's website:

www.tpicap.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFEIIILLVIF
Date   Source Headline
4th Dec 20184:15 pmRNSHolding(s) in Company
3rd Dec 20183:59 pmRNSHolding(s) in Company
16th Nov 20184:08 pmRNSHolding(s) in Company
16th Nov 20183:42 pmRNSDirector Declaration
14th Nov 201812:19 pmRNSHolding(s) in Company
14th Nov 201811:03 amRNSDirector/PDMR Shareholding
13th Nov 20183:52 pmRNSDirector/PDMR Shareholding
9th Nov 20183:29 pmRNSHolding(s) in Company
7th Nov 201812:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20183:23 pmRNSHolding(s) in Company
2nd Nov 20187:00 amRNSTrading Statement
2nd Nov 20187:00 amRNSAcquisition
25th Oct 201810:06 amRNSHolding(s) in Company
2nd Oct 20184:24 pmRNSDirector/PDMR PCA Share Acquisition
25th Sep 20184:35 pmRNSDirector/PDMR Shareholding
25th Sep 20184:34 pmRNSDirector/PDMR Shareholding
18th Sep 20183:20 pmRNSDirector/PDMR Shareholding
12th Sep 20185:14 pmRNSHolding(s) in Company
10th Sep 201812:00 pmRNSHolding(s) in Company
3rd Sep 20187:00 amRNSDirectorate Change
3rd Sep 20187:00 amRNSDirector/PDMR Shareholding
28th Aug 201811:47 amRNSDirector/PDMR Shareholding
10th Aug 201812:39 pmRNSDirector/PDMR Shareholding
9th Aug 20181:12 pmRNSDirector/PDMR Shareholding
7th Aug 20183:38 pmRNSDirector/PDMR Shareholding
7th Aug 20181:08 pmRNSDirector/PDMR Shareholding
7th Aug 20187:00 amRNSFinancial and Interim Management Report
3rd Aug 20185:48 pmRNSHolding(s) in Company
3rd Aug 20188:23 amRNSHolding(s) in Company
1st Aug 20185:26 pmRNSHolding(s) in Company
31st Jul 201811:00 amRNSListing Rule 9.6.14R(2) Notification
13th Jul 20184:32 pmRNSHolding(s) in Company
12th Jul 20183:36 pmRNSHolding(s) in Company
10th Jul 20187:00 amRNSTrading update and directorate changes
6th Jul 20182:59 pmRNSHolding(s) in Company
3rd Jul 20184:06 pmRNSHolding(s) in Company
3rd Jul 20184:06 pmRNSHolding(s) in Company
26th Jun 20185:05 pmRNSDirector/PDMR Shareholding
21st Jun 20181:00 pmRNSDirectorate Change
18th Jun 201810:06 amRNSDirector/PDMR Shareholding
30th May 20187:00 amRNSTP ICAP announces Chairman's intention to retire
30th May 20187:00 amRNSDirectorate Change
18th May 20183:04 pmRNSHolding(s) in Company
15th May 20184:38 pmRNSHolding(s) in Company
11th May 20183:56 pmRNSDirector/PDMR Shareholding
10th May 20184:11 pmRNSResult of AGM
10th May 20187:00 amRNSAGM Statement and Trading Update
9th Apr 20183:51 pmRNSDirector/PDMR Shareholding
5th Apr 20183:13 pmRNSAnnual Financial Report
29th Mar 20187:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.